Hot Mandates: Impact-Focused Venture Fund

12 Apr

The venture fund is an impact, for-profit venture fund with a philanthropic component based in Burlingame, CA. The fund focuses on early/translational stage investments in the diagnosis and treatment of brain-related diseases. The firm is actively investing from its second fund, which closed in 2017. Initial investments will generally range from $200,000-1 million. The firm prefers to invest in the USA but also considers investing in companies based in Canada. While the fund is a for-profit investor, the firm allocates a portion of its investment returns to brain health charities.

The fund invests in therapeutics, medical devices and diagnostics for brain diseases. The firm prefers to invest in companies at the translational stage development (moving from preclinical to clinic). While the firm will consider investments in any area of brain-related treatment and diagnosis, there is high interest in technologies that provide meaningful approaches to multiple brain disease to benefit patients, including drug delivery across the blood-brain barrier, personalized medicine, and molecularly targeted therapeutics. Investments may be considered in any brain-related disease, and the fund’s previous investments include companies working in the fields of neurodegenerative diseases (including Alzheimer’s disease and other forms of dementia), stroke (ischemic and hemorrhagic), memory disorders, traumatic brain injury, and other diseases of the central nervous system (including Parkinson’s disease, epilepsy and neuropathic pain).

The fund does not have any fixed requirements for companies or management teams. Among other factors, the fund considers the length of time it will take before a company’s products begin to benefit patients, as the fund would prefer that its investments have an impact within a reasonable timeframe. The firm works closely with brain health foundations to source new technologies.

If you are interested in more information about this investor and other investors tracked by LSN, please email LHI@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: